Recruiting Geographic Atrophy Studies in Athens
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer (TNBC). The main goal of this study is to learn if people treated with sac...
Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
This study aims to estimate the pharmacokinetics (PK) of posaconazole (POS, MK-5592) intravenous (IV) and powder for oral suspension (PFS) formulations in pediatric participants \<2 years of age with ...
About Geographic Atrophy Clinical Trials in Athens
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 2 geographic atrophy clinical trials recruiting participants in Athens, ALABAMA. These studies are seeking a combined 1,040 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in Athens — FAQ
Are there geographic atrophy clinical trials in Athens?
Yes, there are 2 geographic atrophy clinical trials currently recruiting in Athens, ALABAMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Athens?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Athens research site will contact you about next steps.
Are clinical trials in Athens free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Athens studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 2 active trials in Athens are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated March 2, 2026 from ClinicalTrials.gov